| growth of tick-borne encephalitis virus (european subtype) in cell lines from vector and non-vector ticks. | we undertook a comparative study of the susceptibility of different tick cell lines to infection with the european subtype of tick-borne encephalitis virus (tbev), prototype strain neudoerfl. the growth of tbev was investigated in lines derived from vector ixodes ricinus l. ticks (ire/ctvm18, 19, and 20), as well as non-vector ticks, namely ixodes scapularis say (ide2), boophilus microplus canestrini (bme/ctvm2), hyalomma anatolicum anatolicum koch (hae/ctvm9), rhipicephalus appendiculatus neuma ... | 2008 | 18602711 |
| tick-borne pathogens and associated co-infections in ticks collected from domestic animals in central china. | ticks can transmit a number of pathogens to humans and domestic animals. tick borne diseases (tbds), which may lead to organ failure and death have been recently reported in china. 98.75% of the total cases (>1000) in henan provinces have been reported in xinyang city. therefore, the aims of this study were to investigate the fauna of ticks and detect the potential pathogens in ticks in xinyang, the region of central china. | 2014 | 24886497 |
| vaccination against bm86 homologues in rabbits does not impair ixodes ricinus feeding or oviposition. | human tick-borne diseases that are transmitted by ixodes ricinus, such as lyme borreliosis and tick borne encephalitis, are on the rise in europe. diminishing i. ricinus populations in nature can reduce tick exposure to humans, and one way to do so is by developing an anti-vector vaccine against tick antigens. currently, there is only one anti-vector vaccine available against ticks, which is a veterinary vaccine based on the tick antigen bm86 in the gut of rhipicephalus microplus. bm86 vaccine f ... | 2015 | 25919587 |